For 2026, the update would be 75% of the Medicare Economic Index and 10% every year from 2027 onward. 

Algernon Pharmaceuticals Inc. plans to deploy the compact PET imaging system from Swiss firm Positrigo, cleared by the U.S. FDA last year. 

Such assistance is increasingly necessary given rising volumes of CCTA scans necessary to assess chest pain—the primary cause of outpatient and ED visits. 

Investigators say the doctor “committed sexual acts with almost all the women who entered his office alone."

These findings could be beneficial for women with dense breasts, which increase the risk of developing cancer while making it significantly more difficult to detect. 

Andrew Witty is stepping down as CEO of UnitedHealth Group, citing "personal reasons."  Former CEO Stephen J. Hemsley has taken over, the company announced Tuesday.

Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997.

For some, the FDA is moving too fast in its drive to adopt generative AI agency-wide. 

A multidisciplinary team of breast radiologists, nurses, patient navigators, medical assistants and technologists worked to implement the program at Denver Health. 

The American Society of Nuclear Cardiology wants the feds to protect these vital imaging products from tariffs, highlighting barriers to U.S. production. 

Hospitals are seeking to carve out women’s imaging into a separate capability, with mammo expected to see 9% volume growth through 2028, experts estimate. 

The New York investment group, which also owns Akumin, is reportedly "inches" from acquiring Australia's largest diagnostic imaging provider.